S-Nitroso-N-acetylpenicillamine (SNAP) Impregnated Silicone Foley Catheters: A Potential Biomaterial/Device to Prevent Catheter-Associated Urinary Tract Infections

ACS Biomaterials Science and Engineering

Volumn 1, Issue 6, 2015, Pages 416-424

  Colletta, Alessandro ^a   Wu, Jianfeng ^a   Wo, Yaqi ^a   Kappler, Michael ^b   Chen, Hao ^b   Xi, Chuanwu ^a   Meyerhoff, Mark E ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Biocrede Inc   (United States)

Author keywords

antibiofilm; biocompatibility; long term NO release; nitric oxide; SNAP impregnated Foley catheters

Indexed keywords

BIOMATERIAL; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; POLYMER; SILICONE;

ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; BIOFILM; CATHETER ASSOCIATED URINARY TRACT INFECTION; CATHETER INFECTION; CONTROLLED STUDY; FOLEY BALLOON CATHETER; HOSPITAL INFECTION; HOSPITAL PATIENT; INFECTION RATE; LEACHING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84969211353     PISSN: None     EISSN: 23739878     Source Type: Journal    
DOI: 10.1021/acsbiomaterials.5b00032     Document Type: Article

References (57)

1. Von Eiff, C.; Jansen, B.; Kohnen, W.; Becker, K. Infections associated with medical devices: pathogenesis, management and prophylaxis Drugs 2005, 65, 179-214 10.2165/00003495-200565020-00003
2. Umscheid, C. A.; Mitchell, M. D.; Doshi, J. A.; Agarwal, R.; Williams, K.; Brennan, P. J. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs Infect. Control Hosp. Epidemiol. 2011, 32, 101-114 10.1086/657912
3. Maki, D. G.; Tambyah, P. a. Engineering out the risk for infection with urinary catheters Emerg. Infect. Dis. 2001, 7, 342-347 10.3201/eid0702.700342
4. Hooton, T. M.; Bradley, S. F.; Cardenas, D. D.; Colgan, R.; Geerlings, S. E.; Rice, J. C.; Saint, S.; Schaeffer, a. J.; Tambayh, P. a.; Tenke, P. et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 international clinical practice guidelines from the Infectious Diseases Society of America Clin. Infect. Dis. 2010, 50, 625-663 10.1086/650482
5. Oman, K. S.; Makic, M. B. F.; Fink, R.; Schraeder, N.; Hulett, T.; Keech, T.; Wald, H. Nurse-directed interventions to reduce catheter-associated urinary tract infections Am. J. Infect. Control 2012, 40, 548-553 10.1016/j.ajic.2011.07.018
6. Tambyah, P. A.; Knasinski, V.; Maki, D. G. The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care Infect. Control Hosp. Epidemiol. 2002, 23, 27-31 10.1086/501964
7. Donlan, R. M. Biofilms and device-associated infections Emerg. Infect. Dis. 2001, 7, 277-281 10.3201/eid0702.700277
8. Mah, T. F. C.; O'Toole, G. A. Mechanisms of biofilm resistance to antimicrobial agents Trends Microbiol. 2001, 9, 34-39 10.1016/S0966-842X(00)01913-2
9. Jacobsen, S. M.; Stickler, D. J.; Mobley, H. L. T.; Shirtliff, M. E. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis Clin. Microbiol. Rev. 2008, 21, 26-59 10.1128/CMR.00019-07
10. Tapiainen, T.; Hanni, a-M.; Salo, J.; Ikäheimo, I.; Uhari, M. Escherichia coli biofilm formation and recurrences of urinary tract infections in children Eur. J. Clin. Microbiol. Infect. Dis. 2014, 33, 111-115 10.1007/s10096-013-1935-4
11. Stickler, D. J.; Morgan, S. D. Modulation of crystalline Proteus mirabilis biofilm development on urinary catheters J. Med. Microbiol. 2006, 55, 489-494 10.1099/jmm.0.46404-0
12. Stickler, D. J. Bacterial biofilms in patients with indwelling urinary catheters Nat. Clin. Pract. Urol. 2008, 5, 598-608 10.1038/ncpuro1231
13. Nicolle, L. E. Catheter associated urinary tract infections Antimicrob. Resist. Infect. Control 2014, 3, 23 10.1186/2047-2994-3-23
14. Davenport, K.; Keeley, F. X. Evidence for the use of silver-alloy-coated urethral catheters J. Hosp. Infect. 2005, 60, 298-303 10.1016/j.jhin.2005.01.026
15. Pickard, R.; Lam, T.; Maclennan, G.; Starr, K.; Kilonzo, M.; McPherson, G.; Gillies, K.; McDonald, A.; Walton, K.; Buckley, B. et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial- and antiseptic-impregnated urethral Health Technol. Assess. 2012, 16, 1-197 10.3310/hta16470
16. Tenke, P.; Köves, B.; Johansen, T. E. B. An update on prevention and treatment of catheter-associated urinary tract infections Curr. Opin. Infect. Dis. 2014, 27, 102-107 10.1097/QCO.0000000000000031
17. MacMicking, J.; Xie, Q. W.; Nathan, C. Nitric oxide and macrophage function Annu. Rev. Immunol. 1997, 15, 323-350 10.1146/annurev.immunol.15.1.323
18. Cai, W.; Wu, J.; Xi, C.; Ashe, A. J.; Meyerhoff, M. E. Carboxyl-ebselen-based layer-by-layer films as potential antithrombotic and antimicrobial coatings Biomaterials 2011, 32, 7774-7784 10.1016/j.biomaterials.2011.06.075
19. Riccio, D. A.; Schoenfisch, M. H. Nitric oxide release: Part I. Macromolecular scaffolds Chem. Soc. Rev. 2012, 41, 3731 10.1039/c2cs15272j
20. Barraud, N.; Schleheck, D.; Klebensberger, J.; Webb, J. S.; Hassett, D. J.; Rice, S. A.; Kjelleberg, S. Nitric oxide signaling in Pseudomonas aeruginosa biofilms mediates phosphodiesterase activity, decreased cyclic Di-GMP levels, and enhanced dispersal J. Bacteriol. 2009, 191, 7333-7342 10.1128/JB.00975-09
21. Cai, W.; Wu, J.; Xi, C.; Meyerhoff, M. E. Diazeniumdiolate-doped poly(lactic-co-glycolic acid)-based nitric oxide releasing films as antibiofilm coatings Biomaterials 2012, 33, 7933-7944 10.1016/j.biomaterials.2012.07.027
22. Ren, H.; Wu, J.; Xi, C.; Lehnert, N.; Major, T.; Bartlett, R. H.; Meyerhoff, M. E. Electrochemically modulated nitric oxide (NO) releasing biomedical devices via copper(II)-Tri(2-pyridylmethyl)amine mediated reduction of nitrite ACS Appl. Mater. Interfaces 2014, 6, 3779-3783 10.1021/am406066a
23. Höfler, L.; Koley, D.; Wu, J.; Xi, C.; Meyerhoff, M. E. Electromodulated release of nitric oxide through polymer material from reservoir of inorganic nitrite salt RSC Adv. 2012, 2, 6765-6767 10.1039/c2ra20853a
24. Barraud, N.; Hassett, D. J.; Hwang, S.-H.; Rice, S. a; Kjelleberg, S.; Webb, J. S. Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa J. Bacteriol. 2006, 188, 7344-7353 10.1128/JB.00779-06
25. Brisbois, E. J.; Handa, H.; Major, T. C.; Bartlett, R. H.; Meyerhoff, M. E. Long-term nitric oxide release and elevated temperature stability with S-nitroso-N-acetylpenicillamine (SNAP)-doped Elast-eon E2As polymer Biomaterials 2013, 34, 6957-6966 10.1016/j.biomaterials.2013.05.063
26. Lee, J. N.; Park, C.; Whitesides, G. M. Solvent compatibility of poly(dimethylsiloxane)-based microfluidic devices Anal. Chem. 2003, 75, 6544-6554 10.1021/ac0346712
27. Elliott, T. S. Role of antimicrobial central venous catheters for the prevention of associated infections J. Antimicrob. Chemother. 1999, 43, 441-446 10.1093/jac/43.4.441
28. Sexton, Daniel J; Muruganandam, Arumugam; McKenney, Donald J; Mutus, B. Visible light photochemical release of nitric oxide from S-nitrosoglutathione: potential photochemotherapeutic applications Photochem. Photobiol. 1994, 59, 463-467 10.1111/j.1751-1097.1994.tb05065.x
29. Shishido, S.; de Oliveira, M. G. Polyethylene glycol matrix reduces the rates of photochemical and thermal release of nitric oxide from S-nitroso-N-acetylcysteine Photochem. Photobiol. 2000, 71, 273-280 10.1562/0031-8655(2000)0710273PGMRTR2.0.CO2
30. Frost, M. C.; Meyerhoff, M. E. Controlled photoinitiated release of nitric oxide from polymer films containing S-nitroso-N-acetyl-DL-penicillamine derivatized fumed silica filler J. Am. Chem. Soc. 2004, 126, 1348-1349 10.1021/ja039466i
31. Gilmore, B. F.; Hamill, T. M.; Jones, D. S.; Gorman, S. P. Validation of the CDC biofilm reactor as a dynamic model for assessment of encrustation formation on urological device materials J. Biomed. Mater. Res., Part B 2010, 93, 128-140 10.1002/jbm.b.31567
32. Stephens, A. D.; Watts, R. W. The treatment of cystinuria with N-acetyl-D-penicillamine, a comparison with the results of D-penicillamine treatment Q. J. Med. 1971, 40, 355-370
33. Carpenter, A. W.; Slomberg, D. L.; Rao, K. S.; Schoenfisch, M. H. Influence of scaffold size on bactericidal activity of nitric oxide-releasing silica nanoparticles ACS Nano 2011, 5, 7235-7244 10.1021/nn202054f
34. Lu, Y.; Slomberg, D. L.; Sun, B.; Schoenfisch, M. H. Shape- and nitric oxide flux-dependent bactericidal activity of nitric oxide-releasing silica nanorods Small 2013, 9, 2189-2198 10.1002/smll.201201798
35. Donlan, R. M. Biofilm formation: a clinically relevant microbiological process Clin. Infect. Dis. 2001, 33, 1387-1392 10.1086/322972
36. Ziebuhr, W.; Hennig, S.; Eckart, M.; Kränzler, H.; Batzilla, C.; Kozitskaya, S. Nosocomial infections by Staphylococcus epidermidis: how a commensal bacterium turns into a pathogen Int. J. Antimicrob. Agents 2006, 28 (Suppl 1) S14-S20 10.1016/j.ijantimicag.2006.05.012
37. Fey, P. D.; Olson, M. E. Current concepts in biofilm formation of Staphylococcus epidermidis Future Microbiol. 2011, 5, 917-933 10.2217/fmb.10.56
38. Hall-stoodley, L.; Costerton, J. W.; Stoodley, P. Bacterial biofilms: from the natural environment to infectious diseases Nat. Rev. Microbiol. 2004, 2, 95-108 10.1038/nrmicro821
39. Mack, D.; Davies, A. P.; Harris, L. G.; Jeeves, R.; Pascoe, B.; Knobloch, J. K.; Rohde, H.; Wilkinson, T. S. Biomaterials Associated Infection; Moriarty, T. F.; Zaat, S. A. J.; Busscher, H. J., Eds.; Springer: New York, 2013; pp 25-57.
40. Cabrera-Contreras, R.; Morelos-Ramírez, R.; Galicia-Camacho, A. N.; Meléndez-Herrada, E. Antibiotic resistance and biofilm production in Staphylococcus epidermidis strains, isolated from a tertiary care hospital in Mexico City ISRN Microbiol. 2013, 2013 918921 10.1155/2013/918921
41. Wojtyczka, R. D.; Orlewska, K.; Kepa, M.; Idzik, D.; Dziedzic, A.; Mularz, T.; Krawczyk, M.; Miklasińska, M.; Wasik, T. J. Biofilm formation and antimicrobial susceptibility of Staphylococcus epidermidis strains from a hospital environment Int. J. Environ. Res. Public Health 2014, 11, 4619-4633 10.3390/ijerph110504619
42. Hengzhuang, W.; Wu, H.; Ciofu, O.; Song, Z.; Høiby, N. Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms Antimicrob. Agents Chemother. 2011, 55, 4469-4474 10.1128/AAC.00126-11
43. Jefferson, K. K.; Goldmann, D. A.; Pier, G. B. Use of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilms Antimicrob. Agents Chemother. 2005, 49, 2467-2473 10.1128/AAC.49.6.2467-2473.2005
44. Zheng, Z.; Stewart, P. S. Penetration of Rifampin through Staphylococcus epidermidis Biofilms Antimicrob. Agents Chemother. 2002, 46, 900-903 10.1128/AAC.46.3.900-903.2002
45. Brown, Michael R. W.; Allison; David, G.; Gilbert, P. Resistance of bacteria biofilms to antibiotics: a growth-rate related effect? J. Antimicrob. Chemother. 1988, 22, 777-783 10.1093/jac/22.6.777
46. Walters, M. C.; Roe, F.; Bugnicourt, A.; Franklin, M. J.; Stewart, P. S. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin Antimicrob. Agents Chemother. 2003, 47, 317-323 10.1128/AAC.47.1.317-323.2003
47. Jacobsen, S. M.; Stickler, D. J.; Mobley, H. L. T.; Shirtliff, M. E. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis Clin. Microbiol. Rev. 2008, 21, 26-59 10.1128/CMR.00019-07
48. Jones, B. V.; Mahenthiralingam, E.; Sabbuba, N. a; Stickler, D. J. Role of swarming in the formation of crystalline Proteus mirabilis biofilms on urinary catheters J. Med. Microbiol. 2005, 54, 807-813 10.1099/jmm.0.46123-0
49. Broomfield, R. J.; Morgan, S. D.; Khan, A.; Stickler, D. J. Crystalline bacterial biofilm formation on urinary catheters by urease-producing urinary tract pathogens: a simple method of control J. Med. Microbiol. 2009, 58, 1367-1375 10.1099/jmm.0.012419-0
50. Zunino, P.; Sosa, V.; Schlapp, G.; Allen, A. G.; Preston, A.; Maskell, D. J. Mannose-resistant Proteus-like and P. mirabilis fimbriae have specific and additive roles in P. mirabilis urinary tract infections FEMS Immunol. Med. Microbiol. 2007, 51, 125-133 10.1111/j.1574-695X.2007.00285.x
51. Rocha, S. P. D.; Pelayo, J. S.; Elias, W. P. Fimbriae of uropathogenic Proteus mirabilis FEMS Immunol. Med. Microbiol. 2007, 51, 1-7 10.1111/j.1574-695X.2007.00284.x
52. Deupree, S. M.; Privett, B. J.; Backlund, C. J.; Rao, K. S.; Johnson, B.; Coneski, P. N.; Schoenfisch, M. H. Synergy of nitric oxide and silver sulfadiazine against gram-negative, gram-positive, and antibiotic-resistant pathogens Mol. Pharm. 2011, 7, 2289-2296 10.1021/mp100248e.Synergy
53. Hachem, R.; Reitzel, R.; Borne, A.; Jiang, Y.; Tinkey, P.; Uthamanthil, R.; Chandra, J.; Ghannoum, M.; Raad, I. Novel antiseptic urinary catheters for prevention of urinary tract infections: correlation of in vivo and in vitro test results Antimicrob. Agents Chemother. 2009, 53, 5145-5149 10.1128/AAC.00718-09
54. Darouiche, R. O.; Smith, J. A.; Hanna, H.; Dhabuwala, C. B.; Steiner, M. S.; Babaian, R. J.; Boone, T. B.; Scardino, P. T.; Thornby, J. I.; Raad, I. I. Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: a prospective, randomized, multicenter clinical trial Urology 1999, 54, 976-981 10.1016/S0090-4295(99)00288-5
55. Anderson, G. G.; O'Toole, G. A. Innate and induced resistance mechanisms of bacterial biofilms Curr. Top. Microbiol. Immunol. 2008, 322, 85-105
56. Aiassa, V.; Barnes, A. I.; Albesa, I. Resistance to ciprofloxacin by enhancement of antioxidant defenses in biofilm and planktonic Proteus mirabilis Biochem. Biophys. Res. Commun. 2010, 393, 84-88 10.1016/j.bbrc.2010.01.083
57. Hoffman, L. R.; D'Argenio, D. A.; MacCoss, M. J.; Zhang, Z.; Jones, R. A.; Miller, S. I. Aminoglycoside antibiotics induce bacterial biofilm formation Nature 2005, 436, 1171-1175 10.1038/nature03912